Leukemia vs. Lymphoma: The Differences Explained

The question of what the difference is between leukemia and lymphoma is a commonly asked question. We should start by saying that emerging research is demonstrating that, in reality, there is nothing that is different about these two diseases; rather, they are merely two different phases of the very same developing disease.

However, for the time being, we will consider them separate diseases and determine how and why that is.

Leukemia vs. Lymphoma

Both lymphoma and leukemia describe cancers that derive from blood-borne cells. This can mean lymphoblasts, lymphocytes, immunoblasts, plasma cells, and follicle center cells—in fact any blood-borne cells. And according to the American Joint Committee on Cancer (AJCC), at this stage of classification, there is no difference between lymphoma and leukemia; they are both now called lymphoid neoplasms (or lymphoid cancers).

Beyond Lymphoid Neoplasms

After the overreaching term 'lymphoid neoplasm', the next stage in classification is in terms of clinical presentation, and here is where the terms lymphoma and leukemia return and have some value:

Does the disease produce tissue masses (tumors) in the lymph nodes, or at extranodal sites? If so, it is a lymphoma.

Is the disease found only in circulating blood and not in form tissue masses? If so, it is a leukemia.

If the disease does both of these things, it is called a lymphoma/leukemia. Examples of this include small lymphocytic lymphoma and chronic lymphocytic leukemia are different phases of the same disease. The same is true for lymphoblastic lymphoma and acute lymphoblastic leukemia.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap